为何我们需要血管炎和系统性红斑狼疮临床试验指南。
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.
作者信息
Mukhtyar Chetan, Boumpas Dimitrios, Gordon Caroline, Gross Wolfgang, Jayne David, Luqmani Raashid
出版信息
Ann Rheum Dis. 2007 May;66(5):569-70. doi: 10.1136/ard.2006.065854.
Abstract
See linked article, p 605
摘要
见相关文章，第605页
相似文献
1
Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.为何我们需要血管炎和系统性红斑狼疮临床试验指南。
Ann Rheum Dis. 2007 May;66(5):569-70. doi: 10.1136/ard.2006.065854.
2
Lupus clinical trials: medication failure or failure in study design.狼疮临床试验：药物治疗失败还是研究设计失败。
Rev Bras Reumatol. 2011 Sep-Oct;51(5):410-1.
3
Data quality challenges in systemic lupus erythematosus trials: how can this be optimized?系统性红斑狼疮试验中的数据质量挑战：如何优化？
Curr Rheumatol Rep. 2012 Aug;14(4):324-33. doi: 10.1007/s11926-012-0261-7.
4
Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.羟氯喹对一名日本系统性红斑狼疮患者皮肤血管炎的有益作用。
J Dermatol. 2017 Apr;44(4):e52-e53. doi: 10.1111/1346-8138.13560. Epub 2016 Aug 29.
5
Time to change the primary outcome of lupus trials.是时候改变狼疮试验的主要结局了。
Ann Rheum Dis. 2019 May;78(5):581-582. doi: 10.1136/annrheumdis-2018-213788. Epub 2018 Jun 19.
6
Treatment-resistant systemic lupus erythematosus-associated hypocomplementic urticarial vasculitis successfully treated with belimumab.贝利尤单抗成功治疗难治性系统性红斑狼疮相关低补体血症性荨麻疹性血管炎
Australas J Dermatol. 2023 May;64(2):301-303. doi: 10.1111/ajd.13995. Epub 2023 Feb 6.
7
New therapies in systemic lupus erythematosus--trials, troubles and tribulations--working towards a solution: part 2--the politically incorrect version.系统性红斑狼疮的新疗法——试验、问题与磨难——寻求解决方案：第2部分——非正统版本
Lupus. 2009 Feb;18(2):101-3. doi: 10.1177/0961203308100843.
8
Urinary tract involvement in systemic lupus erythematosus: coexistence with lupus mesenteric vasculitis or intestinal pseudo-obstruction?系统性红斑狼疮的泌尿系统受累：与狼疮性肠系膜血管炎或肠道假性梗阻并存？
Semin Arthritis Rheum. 2015 Feb;44(4):e9. doi: 10.1016/j.semarthrit.2014.05.018. Epub 2014 May 27.
9
Outcome measures to be used in clinical trials in systemic lupus erythematosus.系统性红斑狼疮临床试验中使用的结局指标。
J Rheumatol. 1999 Feb;26(2):490-7.
10
Vasculitis Mimicking Pseudo Erysipelas in Systemic Lupus Erythematosus.系统性红斑狼疮中模仿假性丹毒的血管炎
Acta Derm Venereol. 2019 Dec 1;99(13):1295-1296. doi: 10.2340/00015555-3334.
本文引用的文献
1
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.欧洲抗风湿病联盟关于系统性血管炎临床研究和/或临床试验的建议：聚焦抗中性粒细胞胞浆抗体相关血管炎
Ann Rheum Dis. 2007 May;66(5):605-17. doi: 10.1136/ard.2006.062711. Epub 2006 Dec 14.
2
Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?狼疮性肾炎的最佳治疗方法：何种治疗及适用于何人？
Nat Clin Pract Rheumatol. 2005 Nov;1(1):22-30. doi: 10.1038/ncprheum0016.
3
From autonomy to accountability: the role of clinical practice guidelines in professional power.从自主性到问责制：临床实践指南在专业权力中的作用。
Perspect Biol Med. 2005 Autumn;48(4):490-501. doi: 10.1353/pbm.2005.0096.
4
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.弥漫性增殖性狼疮性肾炎的治疗：随机对照试验的荟萃分析
Am J Kidney Dis. 2004 Feb;43(2):197-208. doi: 10.1053/j.ajkd.2003.10.012.
5
Design, quality, and bias in randomized controlled trials of systemic lupus erythematosus.系统性红斑狼疮随机对照试验的设计、质量与偏倚
J Rheumatol. 2003 May;30(5):979-84.
6
The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.脉冲环磷酰胺在抗中性粒细胞胞浆抗体相关性血管炎中的价值：荟萃分析与批判性综述
Nephrol Dial Transplant. 2001 Oct;16(10):2018-27. doi: 10.1093/ndt/16.10.2018.
7
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).韦格纳肉芽肿病的疾病特异性活动指数：对伯明翰血管炎活动评分的修订。系统性血管炎研究国际网络（INSSYS）。
Arthritis Rheum. 2001 Apr;44(4):912-20. doi: 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5.
8
Development and validation of a disease extent index for Wegener's granulomatosis.韦格纳肉芽肿病疾病范围指数的开发与验证
Clin Nephrol. 2001 Jan;55(1):31-8.
9
10
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.用于系统性血管炎损伤标准化临床评估的血管炎损伤指数的开发与初步验证。
Arthritis Rheum. 1997 Feb;40(2):371-80. doi: 10.1002/art.1780400222.
Zotero 插件